Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy
Autore:
Baniel, J; Israilov, S; Segenreich, E; Livne, PM;
Indirizzi:
Rabin Med Ctr, Dept Urol, IL-49100 Petah Tiqwa, Israel Rabin Med Ctr Petah Tiqwa Israel IL-49100 , IL-49100 Petah Tiqwa, Israel Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel Tel Aviv Univ Tel Aviv Israel IL-69978 ac Med, IL-69978 Tel Aviv, Israel
Titolo Testata:
BJU INTERNATIONAL
fascicolo: 1, volume: 88, anno: 2001,
pagine: 58 - 62
SICI:
1464-4096(200107)88:1<58:CEOTFE>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
QUALITY-OF-LIFE; INTRACORPOREAL INJECTION THERAPY; INTRACAVERNOUS INJECTION; PENILE PROSTHESIS; VACUUM; SILDENAFIL; DEVICE; VIAGRA; SATISFACTION; PAPAVERINE;
Keywords:
radical prostatectomy; erectile dysfunction; progressive treatment; sildenafil; vacuum device; intracorporal injection;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
27
Recensione:
Indirizzi per estratti:
Indirizzo: Israilov, S Rabin Med Ctr, Dept Urol, Beilinson Campus, IL-49100 Petah Tiqwa, Israel Rabin Med Ctr Beilinson Campus Petah Tiqwa Israel IL-49100 el
Citazione:
J. Baniel et al., "Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy", BJU INT, 88(1), 2001, pp. 58-62

Abstract

Objective To assess the effectiveness of a progressive local treatment protocol for erectile dysfunction (ED) in patients after undergoing radical retropubic prostatectomy (RRP) for prostate cancer. Patients and Methods The study included 85 patients (mean age 59.5 years, range 50-75) with ED after RRP. Treatment was offered in four progressive phases, with patients passing to the next phase only if they failed the previous one: in phase I patients used a vacuum erection device; in phase II, sildenafil; in phase III, intracorporal injection; and in phase IV, intracorporal injection plus the vacuum erection device. The patients were followedfor 1 year. Results Of the 85 patients, 78 (92%) responded to the vacuum erection device (with an erection sufficient for vaginal penetration), but only 11 (14%)agreed to continue with it at home. Of the remaining 74 patients, 69 with no contraindications were given sildenafil and 14 (20%) had a positive response. Sixty patients were then treated with intracorporal injection and 51 (85%) had a positive response; four of the nine failures in phase iii responded to intracorporal injection plus vacuum therapy. Five patients failed all four protocols. After I year of follow-up, 76 of the 80 patients were successfully continuing treatment at home: seven (9%) used the vacuum erection device, 11(14%) sildenafil, 54 (71%) intracorporal injection and four (5%) intracorporal injection plus the vacuum erection device. Conclusion Overall, this progressive treatment method gave a positive response in 80 of the 85 patients (94%). After 1 year of follow-up, 76 of the 80 patients (95%) continued to respond well. Of all the methods used, intracorporal injection was the most effective for ED after RRP.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 04:51:52